Wellington Management Group
XGN icon

Wellington Management Group’s Exagen XGN Stock Holding History

Wellington Management Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31,948
Closed -$495K – 2132
2019
Q3 		$495K Buy
+31,948
New +$516K ﹤0.01% 1878

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wellington Management Group's XGN Position: Q4 2019 in Review

Wellington Management Group sold out of Exagen (XGN) in Q4 2019, closing a stake of 31,948 shares — an estimated $495K sold.

Wellington Management Group first reported a position in XGN in Q3 2019 and held it in 1 quarter. The position peaked at $495K in Q3 2019. 36 funds tracked by Wall St. Rank hold XGN as of Q4 2019.

  • Wellington Management Group reported no remaining Exagen position as of Q4 2019 after selling out during the quarter.
  • Wellington Management Group sold 31,948 Exagen shares in Q4 2019, an estimated $495K.
  • Wellington Management Group first reported a position in Exagen in Q3 2019 and held it in 1 quarter.
  • Wellington Management Group's Exagen position peaked at $495K in Q3 2019.
  • 36 funds tracked by Wall St. Rank held Exagen as of Q4 2019.

Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.